Le Lézard
Classified in: Health, Science and technology

Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in Texas to Use New Smartphone Compatible, Insertable Cardiac Monitor


The New Confirm RXtm Insertable Cardiac Monitor Allows Physicians to Monitor Patients Remotely

AUSTIN, Texas, Jan. 18, 2018 /PRNewswire/ -- On Nov. 14, 2017, Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center became the first hospital in Texas?and among the first in the nation?to use the new smartphone compatible Confirm Rxtm Insertable Cardiac Monitor (ICM), the world's first and only smartphone compatible ICM designed to help physicians identify even the most difficult-to-detect cardiac arrhythmias, including atrial fibrillation (A Fib)?as well as monitor cardiac arrhythmias?remotely.

The Confirm Rx ICM is designed to continuously monitor a patient's heart rhythm and proactively transmit information via Bluetooth wireless technology to a mobile app, allowing physicians to track their patients remotely and accurately diagnose arrhythmias that may require further treatment.

"What differentiates the Confirm Rx ICM from other implantable monitors is that it doesn't require a home base station to transmit information," Robert Canby, M.D., a cardiac electrophysiologist at TCAI, said. "Instead, it utilizes a secure Bluetooth wireless connection to transmit that data to the patient's smartphone or tablet. This allows the data to then be immediately sent to a monitoring station, rather than waiting until the patient returns home to connect to a base station."

The Confirm RX ICM is implanted just under the skin in the chest during a quick, minimally-invasive outpatient procedure. Once implanted, it continuously monitors heart rhythms to detect a range of cardiac arrhythmias, including irregular heartbeats, such as A Fib.

An arrhythmia is an abnormal heart rhythm that develops when disease or injury disrupts the heart's electrical signals, causing the heart to beat erratically. As the heart begins to beat too fast or too slow, changes in blood flow can expose patients to symptoms such as palpitations, dizziness, shortness of breath or fainting. Left untreated, A Fib can lead to stroke.

While the Confirm Rx ICM continuously monitors for abnormal heart rhythms and transmits data to a patient's physician, the compatible app also allows patients to track symptoms proactively, sync their data with their clinic at any time and view their transmission history without having to contact their clinic to confirm successful data transfers.

Media Contacts:
Erin Ochoa or Tina Shively
Elizabeth Christian Public Relations
(512) 472-9599

 

SOURCE Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: